Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study
- PMID: 34642793
- PMCID: PMC8752534
- DOI: 10.1007/s00432-021-03825-x
Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study
Abstract
Purpose: Limited research suggests that cancer survivors have problems with insurance. Our study aimed to gain insight into the proportion of very long-term (14-24 years post-diagnosis) survivors of breast, colorectal, and prostate cancers who had problems with health (HI) and life (LI) insurance.
Methods: We used data from CAESAR (CAncEr Survivorship-A multi-Regional population-based study). Participants completed questions on change in insurance providers since cancer diagnosis, problems with requesting (additional) HI or LI, and how potential problems were resolved. We conducted logistic regression to determine factors associated with change in statutory HI.
Results: Of the 2714 respondents, 174 (6%) reported having changed HI providers. Most switched between different statutory HI providers (86%), 9% from statutory to private, and 5% from private to statutory. Respondents who changed statutory HI providers were more likely to be prostate cancer survivors (OR 2.79, 95% CI 1.01-7.68) while being ≥ 65 years at time of diagnosis (OR 0.58, 95% CI 0.35-0.96) and having ≥ 2 comorbid conditions (OR 0.61, 95% CI 0.40-0.92) were associated with reduced odds for change. Problems in changing HI were minimal and were resolved with additional contribution. Of the 310 respondents who tried to get LI, 25 respondents reported having difficulties, of whom the majority had their request rejected.
Conclusion: Most cancer survivors did not change their HI nor tried to buy LI after cancer diagnosis. Problems with changing statutory HI were generally resolved with additional contribution while the main problem encountered when buying LI was rejection of request.
Keywords: Cancer survivors; Financial toxicity; Insurance problems; Population-based.
© 2021. The Author(s).
Conflict of interest statement
None declared. The funding source was neither involved in the collection, interpretation, and analysis of the data nor in the decision for the writing and submission of this report for publication.
Similar articles
-
Employment and insurance outcomes and factors associated with employment among long-term thyroid cancer survivors: a population-based study from the PROFILES registry.Qual Life Res. 2016 Apr;25(4):997-1005. doi: 10.1007/s11136-015-1135-z. Epub 2015 Sep 22. Qual Life Res. 2016. PMID: 26395276 Free PMC article.
-
Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - a population-based study.Acta Oncol. 2019 May;58(5):801-810. doi: 10.1080/0284186X.2018.1557340. Epub 2019 Feb 8. Acta Oncol. 2019. PMID: 30736716
-
Rural cancer survivors' health information needs post-treatment.Patient Educ Couns. 2020 Aug;103(8):1606-1614. doi: 10.1016/j.pec.2020.02.034. Epub 2020 Feb 27. Patient Educ Couns. 2020. PMID: 32147307 Free PMC article.
-
Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies.J Cancer Surviv. 2020 Jun;14(3):386-392. doi: 10.1007/s11764-020-00855-1. Epub 2020 Jan 13. J Cancer Surviv. 2020. PMID: 31933148 Review.
-
Cancer survivor late-effects, chronic health problems after cancer treatment: what's the evidence from population and registry data and where are the gaps?Curr Opin Support Palliat Care. 2024 Mar 1;18(1):55-64. doi: 10.1097/SPC.0000000000000692. Epub 2024 Dec 30. Curr Opin Support Palliat Care. 2024. PMID: 38170192 Review.
Cited by
-
Effects of the right to be forgotten for childhood or breast cancer survivors: results of a quasi-experimental study in France.J Cancer Surviv. 2025 Jun 4. doi: 10.1007/s11764-025-01830-4. Online ahead of print. J Cancer Surviv. 2025. PMID: 40467965
References
-
- Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376. 10.1093/jnci/85.5.365 - PubMed
-
- Arndt V, Koch-Gallenkamp L, Jansen L (2017) Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol 56:190–197. 10.1080/0284186x.2016.1266089 - PubMed
-
- Busse R, Blümel M (2014) Germany: health system review. Health Syst Transit 16:1–296.https://www.euro.who.int/__data/assets/pdf_file/0008/255932/HiT-Germany.pdf - PubMed
-
- Busse R, Blümel M, Knieps F, Bärnighausen T (2017) Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet 390:882–897. 10.1016/S0140-6736(17)31280-1 - PubMed
-
- Buttner M, Konig HH, Lobner M, Breist S, Konnopka A, Dietz A, Riedel-Heller S, Singer S (2019) Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal study. Support Care Cancer 27:2221–2228. 10.1007/s00520-018-4498-1 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical